Last reviewed · How we verify

NCT04367259

Single Puncture Arthrocentesis vs Double Puncture Arthrocentesis

Completed NA Last updated 29 April 2020
What this trial tests

NA trial testing TMJ Arthrocentesis in Arthrocentesis in 36 participants. Completed in 1 December 2019.

Timeline
1 January 2017
Primary endpoint
1 November 2019
1 December 2019

Quick facts

Lead sponsorErzincan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment36
Start date1 January 2017
Primary completion1 November 2019
Estimated completion1 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Erzincan University

Who can join

Adults 21 to 59, any sex, with Arthrocentesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study was to compare the treatment efficacy of single puncture arthrocentesis (SPA) and double puncture arthrocentesis (DPA) techniques in Temporomandibular joint (TMJ) disc displacement without reduction (DDwoR).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of TMJ Arthrocentesis

Trials testing the same drug.

Other recruiting trials for Arthrocentesis

Currently open trials in the same condition.

Other Erzincan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04367259.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing